Related Experiment Video
Updated: Jun 25, 2026
07:48
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Potential novel targets in breast cancer
1UMDNJ-New Jersey Medical School, MSB, Rm. E-579, 185 South Orange Ave, Newark, NJ 07103, USA. rameshwa@umdnj.edu
Current Pharmaceutical Biotechnology
|February 10, 2009
Summary
This review explores breast cancer cell subsets, like cancer stem cells (CSCs) and progenitors, and their interaction with the bone marrow microenvironment. Understanding these interactions may reveal new diagnostic methods and drug targets for breast cancer treatment.
Area of Science:
- Oncology
- Cell Biology
- Cancer Stem Cell Biology
Background:
- Breast cancer involves diverse cell subsets, including cancer stem cells (CSCs) and progenitors, with distinct properties.
- The bone marrow microenvironment significantly influences cancer cell behavior, self-renewal, and development.
- Understanding CSCs and their interactions is crucial for effective breast cancer prognosis and treatment.
Purpose of the Study:
- To review the properties of breast cancer cell subsets and their developmental pathways.
- To explore the role of the bone marrow microenvironment in breast cancer progression and recurrence.
- To propose novel approaches for identifying CSCs and their interactions for therapeutic development.
Main Methods:
- Review of existing literature on cancer stem cells, progenitors, and bone marrow microenvironment interactions.
- Discussion of a reductionist approach for identifying cancer cell subsets within the bone marrow.
- Analysis of proposed mechanisms of cancer cell interaction with stromal and stem cells, including gap junctions and microRNA sharing.
Main Results:
- Characterization of different cancer cell subsets can lead to unique signatures for prognosis and diagnosis.
- Mesenchymal stem cells may play a protective role, facilitating cancer cell communication with stromal cells.
- Breast cancer progresses through distinct stages in the bone marrow, influencing survival and potential relapse.
Conclusions:
- New approaches are needed to identify breast cancer stem cells and their bone marrow interactions.
- Understanding these interactions can lead to novel drug targets and treatment strategies.
- Targeting CSCs and their microenvironment interactions holds promise for improving breast cancer outcomes.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...